Please use this identifier to cite or link to this item:
Authors: Klimek, Ludger
Hagemann, Jan
Döge, Julia
Freudelsperger, Laura
Cuevas, Mandy
Klimek, Felix
Hummel, Thomas
Title: Olfactory and gustatory disorders in COVID-19
Online publication date: 5-Jan-2023
Year of first publication: 2022
Language: english
Abstract: Loss of olfaction is one of the symptoms most commonly reported by patients with coronavirus disease 2019 (COVID-19). Although the spontaneous recovery rate is high, recent studies have shown that up to 7% of patients remain anosmic for more than 12 months after the onset of infection, leaving millions of people worldwide suffering from severe olfactory impairment. Olfactory training remains the first recommended treatment. With the continued lack of approved drug treatments, new therapeutic options are being explored. This article reviews the current state of science on COVID-19-related olfactory disorders, focusing on epidemiology, pathophysiology, cure rates, currently available treatment options, and research on new treatments.
DDC: 610 Medizin
610 Medical sciences
Institution: Johannes Gutenberg-Universität Mainz
Department: FB 04 Medizin
Place: Mainz
Version: Published version
Publication type: Zeitschriftenaufsatz
License: CC BY
Information on rights of use:
Journal: Allergo journal international
Pages or article number: 243
Publisher: Springer Nature Switzerland AG
Publisher place: Cham
Issue date: 2022
ISSN: 2197-0378
Publisher DOI: 10.1007/s40629-022-00216-7
Appears in collections:DFG-491381577-H

Files in This Item:
  File Description SizeFormat
olfactory_and_gustatory_disor-20221121100003891.pdf297.85 kBAdobe PDFView/Open